Proteomics screening of adenosine triphosphate-interacting proteins in the liver of diazinon-treated rats

Abstract

Aim: Diazinon (DZN) is one of the most important organophosphorus compounds used to control pests in agriculture in many countries. Several studies have shown that exposure to DZN may alter protein expression in the liver. In order to further investigate the mechanism of DZN toxicity, differentially expressed ATP-interacting proteins, following subacute exposure to toxin, were separated and identified in rat liver. Main methods: Male rats were equally divided into four groups: control (corn oil) and DZN (15 mg/kg) by gavage once a day for 4 weeks. After homogenization of liver tissue, lysates were incubated ATP-sepharose beads. After several washes, ATP-interacting proteins were eluted and separated on 2-D polyacrylamide gels. Deferentially expressed proteins were cut and identified using matrix-assisted laser desorption/ionization/time-of-flight and Mascot database. Identified proteins were classified according to their biological process using protein analysis through evolutionary relationships (PANTHER) Web site. Key finding: In this work, we showed that several key proteins involved in biological processes such as antioxidant system, oxidative stress, apoptosis, and metabolism were differentially expressed after subacute exposure to DZN.

Keywords

Affinity chromatography diazinon proteomics ATP-interacting proteins

Introduction

Organophosphorus (OP) compounds, such as diazinon (O,O-diethyl-O-(2-isopropyl-6-methyl-4-pyrimidin-y)phosphorothionate; DZN), are extensively used as agricultural pesticides to control insect pests.¹ DZN has made great contributions to food production, but excessive use of this toxic chemical in agriculture has developed severe health hazards.^2,3 DZN is metabolized to diazoxon, which is an acetylcholinesterase inhibitor, and may contribute to the toxic effects of DZN.⁴

An in vivo study showed that exposure to DZN increased activity of alanine transaminase, aspartate transaminase, and alkaline phosphatase in serum.⁵ Moreover, DZN could interfere with lipid metabolism and increase the levels of phospholipids, triglycerides, and cholesterol. Furthermore, DZN may induce oxidative stress.⁶

Subacute studies revealed that exposure to parathion, malathion, and DZN could significantly increase oxidative stress biomarkers such as lipid peroxidase, reduce antioxidant defense enzymes including glutathione, enzyme-chelating free radicals, glutathione peroxidase, catalase, superoxide dismutase, and glutathione reductase. Vitamins E and C could reduce DZN-induced oxidative stress.⁷ In recent years, most of the studies about chronic exposure to OP poisoning showed that these toxins could induce apoptosis by activating caspases 9 and 3.^8
–10

Many reports have revealed that OPs induce hepatotoxicity.^11

–14 Liver has a significant role in activation, exertion, and detoxification of OP compounds. Previous studies have shown that OPs alter the expression pattern of different enzymes such as antioxidant enzymes in the liver.^15,16 DZN accelerates hepatocytes death and the loss of cellular ATP.¹⁷

The aim of this study was to investigate differentially expressed proteins that could interact with purine group in adenine molecule in the liver tissues of rat after subacute exposure to DZN. This was achieved through pull down purification of proteins using ATP-sepharose, followed by two-dimensional (2-D) gel electrophoresis for protein separation and matrix-assisted laser desorption/ionization/time-of-flight (MALDI/TOF/TOF) for protein identification.

Materials and methods

Animals

Animal treatment

Adult male Wistar rats weighing 250–300 g were provided by Animal Center, School of Pharmacy, Mashhad University of Medical Sciences, Iran. Rats were maintained at 23 ± 1°C and 12 h-light/12 h-dark cycles with free access to food and water. All animal procedures were approved by the Ethical Committee Acts of Mashhad University of Medical Sciences for care and use of laboratory animals (permission # 89609). Twelve rats were equally divided (each group contains six rats) into control group (corn oil) and DZN-treated group (15 mg/kg). Both groups were administrated via gavage once a day for 4 weeks. After 4 weeks, rats were killed, and the liver tissues were removed and washed in normal saline, then stored at −80°C until further use.

Preparation of ATP-sepharose complex

According to manufacturer’s instruction, 0.5 g of ATP-sepharose beads (Sigma, St Louis, Missouri, USA) was suspended in sodium chloride (NaCl) solution (3 mM, 5 ml) and shaked for 5 min at 4°C to swell. Then the beads were centrifuged at 1000g for 1 min at 4°C. Supernatants were removed, and the beads were washed three times with double-distilled water (ddH₂O; 1000 µl) and stored at 4°C until use.

Tissue preparation

Two hundred milligrams of liver tissues was homogenized in 1 ml of lysis buffer containing Tris (50 mM, pH 7.4), ethylene glycol tetraacetic acid (2 mM), ethylenediaminetetraacetic acid (1 mM), sodium orthovanadate (1 mM), sodium fluoride (10 mM), NaCl (150 mM), 2-mercaptoethanol (10 mM), complete protease inhibitor cocktail (2 µl, Sigma, USA), and phenylmethylsulfonyl fluoride (1 mM) using a polytron homogenizer (Kinematica, Switzerland). After sonication (UP100 H, Hielscher, Germany) for 40 s, homogenates were centrifuged (Hettich Universal 320 R, Germany) at 10,000g for 10 min at 4°C. Finally, total protein contents were determined using a Bradford protein assay kit (BioRad, Hercules, California, USA). Protein concentrations of lysates were adjusted to 1 mg/ml.

Affinity chromatography

One hundred microliters of tissue extracts, containing the same amount of protein for both groups were transferred to ATP-sepharose beads and shaked for 10 min at 4°C. After a brief centrifugation at 1000g for 1 min at 4°C, supernatants were removed and discarded. Then the beads were washed three times with ddH₂O (1000 µl). NaCl solution (2 mM, 1 ml) was added to the beads and shaken for 5 min at 4°C. After a brief centrifugation, supernatants–containing ATP-interacting proteins were collected and transferred to clean microtubes. The latter step was repeated three times, and supernatants were pooled. For desalting, pooled samples were dialyzed against ddH₂O for 3 days at 4°C using a semipermeable membrane with a 2000 Da cutoff Spectra/Por^® (Rancho Dominguez, CA, USA). Finally, samples were freeze-dried and stored at −80°C until use.

2-D Gel electrophoresis

Briefly, isoelectric focusing was performed. Then strips were placed on top of 12% sodium dodecyl sulfate–polyacrylamide gels and ceiled with agarose gels. Electrophoresis was carried out at 120 V for 40 min per gel at 20°C. After silver staining, gels were scanned, and the stained gels were scanned on Image scanner III (Epson, Japan). All procedures were carried out according to procedure carried out in our laboratory.¹⁸

Intensities of protein spots in control and DZN-treated rats were analyzed using Image Master Platinum 6.0 software (GE Healthcare, Cleveland, Ohio, USA). Protein spots normalization was performed against the total volumes of all the detected spots. To analyze statistically different spots in treatment and control groups, Student’s t-test was performed. The values of p ˂ 0.05 were considered as statistically different. Differentially expressed ATP-interacting protein spots were manually excised and transferred to microtubes-containing 1% acid acetic, which was then sent to the Center of Genomic Sciences at University of Hong Kong for in-gel digestion and mass analysis using MALDI/TOF/TOF analyzer.

Mass analysis and database searching for protein identification

Proteins were identified using MALDI/TOF/TOF analyzer (Applied Biosystems, Foster City, California, USA) and Web-based Mascot software (version 2.1.0, Matrix Science, London, UK). Mascot search parameters were set as follows: taxonomy, rattus (expressed sequence tag) or all entries; peptide charge: +1, monoisotopic; mass spectrometry (MS)/MS fragment tolerance: ± 0.2 Da; precursor mass tolerance: 75 ppm; cysteine carbamidomethylation for fixed modification; and methionine oxidation for variable modification. Proteins with confidence intervals (CIs) of 100% were accepted.

Classifications and network interaction analysis

For classification of altered proteins protein analysis through evolutionary relationships (PANTHER) online database (http://www.pantherdb.org) was used. This Web site categorizes proteins in different categories according to their biological process and biological pathways.¹⁹

Results

To analyze the effect of DZN on expression pattern of ATP-interacting proteins, pull down assay was performed using ATP-sepharose beads. Then proteins were separated and identified by 2-D gel electrophoresis and MS analysis. In this project, 12 proteins were identified (Figures 1 and 2).

Figure 1.

Two-dimensional gel electrophoresis of control targets in rat liver.

Figure 2.

Two-dimensional gel electrophoresis of DZN targets in rat liver. DZN: diazinon.

To classify proteins according to biological processes, their SwissProt accession numbers were submitted to PANTHER database (Figure 3).

Figure 3.

Biological process classification of DZN target proteins in rat liver by PANTHER classification system. DZN: diazinon; PANTHER: protein analysis through evolutionary relationships.

The proteins were divided in three classes including metabolic process, response to stimuli, immune system process, localization, cellular component organization, and cellular process. Most of the identified proteins were involved in metabolic process.

The information of identified proteins including protein name/gene names, size, Swiss Prot accession number, sample name, CI%, protein score, sequence coverage (%), theoretical isoelectric point, and sequence with the highest ion score are listed in Table 1.

Table 1.

Identified DZN target proteins in rat liver by MALDI/TOF/TOF.

Protein name	Accession no.	Mass	Score protein	Matches	Matched peptide sequence	Sequencing	Coverage	pI	Fold change DZN/control	CI%	Total ion, CI%	Total ion score	Biological function (PANTHER classification)
Malate dehydrogenase, cytoplasmic (GN = MDH1)	15100179	36,631	51	1(1)	K.FVEGLPINDFSR.E	1(1)	3%	6.16	0.53	99.836	99.904	52	Generation of precursor metabolites and energy
													Carbohydrate metabolic process
													Tricarboxylic acid cycle
Proteasome activator complex subunit 1 (GN = PSME1)	61098214	28,730	101	2(1)	K.YFSERGDAVAK.A	2(1)	10%	5.77	1.76	100	100	134	Proteolysis
Glutathione-S-transfrase (GN = GSTA3)	13928688	25,360.3	106	3(2)	R.NRYFPAFEK.V	3(2)	12%	8.78	0.31	100	100	140	Immune system process
Glutathione-S-transfrase (GN = GSTA3)	13928688	25,360.3	106	3(2)	R.NRYFPAFEK.V	3(2)	12%	8.78	0.31	100	100	140	Response to toxin
Catechol O-methyltransferase (GN = COMT)	209156404	29,806	352	4(4)	K.GQIMDAVIR.E	4(4)	25%	5.41	0.26	100	100	431	Neurological system process
Catechol O-methyltransferase (GN = COMT)	209156404	29,806	352	4(4)	K.GQIMDAVIR.E	4(4)	25%	5.41	0.26	100	100	431	Metabolic process
Enoyl CoA hydratase (GN = ECH1)	17530977	31,895.3	254	4(3)	K.FLSHWDHITR.I	4(3)	20%	8.39	0.21	100	100	334	Coenzyme metabolic process
													Vitamin biosynthetic process
													Carbohydrate metabolic process
													Fatty acid beta-oxidation
Nitrilase homolog1 (GN = NIT1)	128485844	32,697	94	2(1)	R.AIESQCYVIAAAQCGR.H	2(1)	8%	5.93	0.31	100	100	115	Metabolic process
Annexin A3 (GN = ANXA3)	401709965	36,569	144	3(3)	K.LTFDEYR.N	3(3)	9%	5.69	1.47	100	100	163	Fatty acid metabolic process
Peroxiredoxin6 (GN = PRDX6)	16758348	24,860	222	4(4)	R.NFDEILR.V	4(4)	16%	5.64	0.65	100	100	227	Metabolic process
Phosphatidylethanolamine- binding protein 1 (GN = PEBP1)	8393910	20,902	213	3(3)	K.FKVESFR.K	3(3)	24%	5.48	0.38	100	100	237	Signal transduction
3-Mercaptopyruvate sulfurtransferase (GN = MPST)	20304123	33,205	162	3(2)	R.RFQVVDAR.A	3(2)	11%	5.88	0.23	100	100	198	Sulfur compound metabolic process
													Response to toxic substance
													Anion transport
Ornithine transcarbamylase (GN = OTC)	6981312	39,918	265	4(3)	R.SLVFPEAENR.K	4(3)	14%	9.12	0.26	100	100	288	Nitrogen compound metabolic process
													Pyrimidine nucleobase metabolic process
													Cellular amino acid biosynthetic process
d-Dopachrome decarboxylase (GN = DOPD)	13162287	13,239	325	3(3)	K.FLTEELSLDQDR.I	3(3)	42%	6.09	1.34	100	100	357	Metabolic process

GN: gene name; pI: isoelectric point; DZN: diazinon; CI: confidence interval; PANTHER: protein analysis through evolutionary relationships; MALDI: matrix-assisted laser desorption/ionization; TOF: time of flight.

Discussion

By combining affinity chromatography and proteomics, 12 ATP-interacting differentially expressed proteins were identified in the liver tissue of DZN-treated rats.

Previously, the effect of chronic exposure to DZN on total proteome was reported.^{7,10,18,20

–23} In this study, we specifically studied the alteration of purine packet-containing proteins such as ATPases and kinases because these proteins are key proteins in many signal transduction pathways. In whole proteomics, proteins like kinases, cannot be detected because of low cellular concentration. Here we tried to concentrate these types of proteins prior to 2-D electrophoresis, so that we got a 2-D with less number of spots as compared to whole proteomics as we reported in Lari et al.¹⁸

Here we introduced some novel proteins involved in DZN toxicity. Besides inhibition of neuronal acetylcholine sterase,^10,20,21 several reports have demonstrated that DZN could affect intracellular systems including apoptosis, oxidant, metabolic enzymes, and cell death.^{7,10,20

–23}

It has been shown that exposure to different concentration of DZN could induce oxidation of protein by decreasing the capacity for scavenging damaged proteins.^7,22,23

This study showed that DZN altered the levels of several ATP-interacting cellular proteins including metabolic enzymes, structural proteins, antioxidant, and apoptotic proteins.

d-Dopachrome decarboxylase (DOPD) involves in the production of melanin precursor as an antioxidant.^24,25 It has been reported that carbon tetrachloride (CCl₄), a known hepatotoxine, hepatitis B virus, and hepatectomy induced overexpression of DOPD by 70%.^5,24,26 Previous studies demonstrated that overexpression of DOPD in healthy hepatocytes increased melanin synthesis and protect cells against oxidative stress in the liver tissue.²⁴ Overexpression of DOPD after exposure to DZN could protect the hepatocytes against DZN-induced oxidative stress.

Phosphatidyl ethanolamine-binding protein (PEBP), also called RAF-1 kinase inhibitor protein, decreased after chronic exposure to DZN. By inhibition of RAF1 and degradation of rapidly accelerated fibrosarcoma (RAF)–mitogen-activated protein kinase (MEK) complex, PEBP could inhibit RAF/MEK/extracellular signal-regulated kinase cascade²⁷ and affect the cell cycle fidelity.²⁸ Moreover, PEBP downregulation could promote cell proliferation and migration of human hepatoma cells.²⁹ It has been shown that low levels of PEBP may protect cancer cells against apoptosis and improve viability of metastatic cancer cells.^30
–32 It has been indicated that chronic stress condition decreased the level of PEBP.³³ PEBP downregulation after chronic exposure to DZN may induce cancer and metastasis in liver tissue.

DZN could reduce the level of catechol-o-methyl transferase (COMT). COMT involves in several detoxification pathways: (1) metabolism of intermediate indolic compounds in melanin synthesis, such as 5,6-dihydroxyindole-2-carboxylic acid, this compound could be readily oxidized to toxic quinone derivatives and (2) metabolism of catechol estrogens, such as 4-hydroxy estradiol, known as a hepatotoxin.^34

–37

Malate dehydrogenase (MDH) was also downregulated by DZN. Cytosolic MDH is a metabolic enzyme involved in the conversion of malate to oxaloacetate.³⁸ Previous study demonstrated that acute and chronic administration of DZN could downregulate MDH in liver tissue. Moreover, decrease of MDH has been accepted as a biomarker of damaged liver.^39
–41 Sastry and coworkers demonstrated that acute and chronic DZN administration resulted in the reduction of total MDH level.

This study showed that DZN increased proteasome activator subunit 1 (PSME). Proteasomes are distributed throughout eukaryotic cells at high concentration, and the main function of PSME is degradation of damaged or useless proteins in an ATP/ubiquitin-dependent process in a non-lysosomal pathway.¹⁸ Proteasomal depredating pathway is essential for various intracellular processes including regulation of gene expression, cell cycle and division, stress response, elimination of damaged proteins, antigen process for immune system, oxidative stress, and apoptosis.⁴² Previous studies revealed that DZN could increase cellular ubiquitinylated proteins and consequently led them to ATP/ubiquitin-dependent proteasomal degradation pathway.⁴³ It could be concluded that PSME increase could be related to increase in cellular ubiquitinylated protein levels.

DZN decreased the level of glutathione-S-transferase alpha3 (GSTα3). This enzyme involves in the cellular detoxification of both xenobiotic and endobiotic compounds. GST catalyzes conjugation of toxins with glutathione and produces less toxic and more hydrophilic products that can then be partially metabolized and excreted.⁴⁴ GSTα3 is well recognized as a serum biomarker of liver toxicity.⁴⁰ Previous reports showed that subchronic DZN administration could reduce the level of GSTα3 in liver.⁴¹ Fujioka and coworkers demonstrated the important role of GSTα3 in OP detoxification.⁴⁵ Decreased level of GSTα3 using DZN showed that DZN could reduce the antioxidant capacity of cell and disturb cellular redox capacity.

Nitrilase homolog1 (NIT1) was also downregulated by DZN. NIT1 is one of the proteins involved in nitrogen compound metabolic process. Several studies revealed that NIT1 has tumor-suppressor properties that can enhance the apoptosis in cancer cells.⁴⁵ Downregulation of NIT1 by DZN may promote cell growth in tumor cells.

Our results showed that DZN increased annexin A3 (ANXA3), a calcium-dependent PEBP. ANXA3 plays a role in the regulation of cellular growth, inflammation, and signal transduction pathways. This protein inhibits phospholipase A2 (PLA2) and induces cleavage of inositol 1,2-cyclic phosphate to form inositol 1-phosphate and promotes inflammation recovery.⁴⁶ Previous studies showed that CCl₄ increased the level of this protein in liver tissue.⁴⁷ Overexpression of ANXA3 promotes metastasis in different cancers.^48,49 ANXA3, using hypoxia-inducible factor-1 pathway by producing vascular endothelial growth factor, has angiogenesis effect.⁵⁰

Enoyl-CoA hydratase (ECH) was downregulated by DZN. ECH involves β-oxidation of fatty acids.⁵¹ Some reports described that ECH dysfunction may produce acute liver encephalopathy, liver dysfunction, and sudden infant death syndrome.⁵² DZN may play role in several metabolic dysfunction through reduction of ECH level.

3-Mercaptopyruvate sulfurtransferase (MPST) was also downregulated by DZN. This enzyme plays a role in cyanide detoxification.⁵³ MPST is an antioxidant enzyme with important role in cellular redox regulation.⁵⁴ This report showed that DZN may induce oxidative stress through decreasing total amount of MPST.

Besides MPST, DZN may induce oxidative stress by peroxiredoxin-6 (PRDX6) downregulation.^55,56 PRDX6 is an antioxidant enzyme that reduces cellular hydrogen peroxide (H₂O₂). This enzyme involves in the activities that are susceptible to cellular redox such as proliferation, signal transduction, and apoptosis.⁵⁶ PRDX6 is a bifunctional enzyme with both peroxidase and PLA2 activities. PRDX6 produces arachidonic acid (AA) using PLA2, which is essential in apoptosis-mediated tumor necrosis factor α (TNF-α).⁵⁶ Downregulation of PRDX6 by DZN may promote cellular susceptibility to H₂O₂-induced apoptosis and decrease apoptosis due to TNF-α in cells.⁵⁶

Conclusion

Using a pull down assay and proteomics approach, pattern of ATP-interacting proteins expression after exposure to DZN was studied. Our data provided some novel insights into the mechanism of DZN hepatotoxicity. We showed that DZN could alter the levels of proteins involved in antioxidant, apoptotic, and metabolic activities of the cells.

Footnotes

Acknowledgment

The authors are thankful to the Vice Chancellor of Research at the Mashhad University of Medical Sciences for the financial support of this project.

Declaration of Conflicting Interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) received no financial support for the research, authorship, and/or publication of this article.

References

Gokcimen

Gulle

Demirin

. Effects of diazinon at different doses on rat liver and pancreas tissues. Pestic Biochem Physiol 2007; 87(2): 103–108.

Abdollahi

Jafari

Jalali

. Chronic toxicity in organophosphate exposed workers. MJIRI 1995; 9: 221–225.

Konstantinou

Hela

Albanis

. The status of pesticide pollution in surface waters (rivers and lakes) of Greece. Part I. Review on occurrence and levels. Environ Pollut 2006; 141(3): 555–570.

Giordano

Afsharinejad

Guizzetti

. Organophosphorus insecticides chlorpyrifos and diazinon and oxidative stress in neuronal cells in a genetic model of glutathione deficiency. Toxicol Appl Pharmacol 2007; 219(2): 181–189.

Strey

Winters

Markiewski

. Partial hepatectomy induced liver proteome changes in mice. Proteomics 2005; 5(1): 318–325.

Kalender

Ogutcu

Uzunhisarcikli

. Diazinon-induced hepatotoxicity and protective effect of vitamin E on some biochemical indices and ultrastructural changes. Toxicology 2005; 211(3): 197–206.

El-Shenawy

El-Salmy

Al-Eisa

. Amelioratory effect of vitamin E on organophosphorus insecticide diazinon-induced oxidative stress in mice liver. Pestic Biochem Physiol 2010; 96(2): 101–107.

Rush

Liu

Hjelmhaug

. Mechanisms of chlorpyrifos and diazinon induced neurotoxicity in cortical culture. Neuroscience 2010; 166(3): 899–906.

Oral

Guney

Demirin

. Endometrial damage and apoptosis in rats induced by dichlorvos and ameliorating effect of antioxidant vitamins E and C. Reprod Toxicol 2006; 22(4): 783–790.

10.

Güney

Oral

Demirin

. Evaluation of caspase-dependent apoptosis during methyl parathion-induced endometrial damage in rats: Ameliorating effect of vitamins E and C. Environ Toxicol Pharmacol 2007; 23(2): 221–227.

11.

Bachowski

Kolaja

. Role of oxidative stress in the mechanism of dieldrin’s hepatotoxicity. Ann Clin Lab Sci 1997; 27(3): 196–209.

12.

Bagchi

Hassoun

. In vitro and in vivo generation of reactive oxygen species, DNA damage and lactate dehydrogenase leakage by selected pesticides. Toxicology 1995; 104(1): 129–140.

13.

Gupta

Datta

Sarkar

. Effect of malathion on antioxidant defence system in human fetus--an in vitro study. Indian J Exp Biol 1992; 30(4): 352–354.

14.

Yamano

Morita

. Hepatotoxicity of trichlorfon and dichlorvos in isolated rat hepatocytes. Toxicology 1992; 76(1): 69–77.

15.

Goel

Dhawan

. Zinc supplementation prevents liver injury in chlorpyrifos-treated rats. Biol Trace Elem Res 2001; 82(1-3): 185–200.

16.

Goel

Dani

Dhawan

. Protective effects of zinc on lipid peroxidation, antioxidant enzymes and hepatic histoarchitecture in chlorpyrifos-induced toxicity. Chem-Biol Interact 2005; 156(2): 131–140.

17.

Nakagawa

Moore

. Role of mitochondrial membrane permeability transition in p-hydroxybenzoate ester-induced cytotoxicity in rat hepatocytes. Biochem Pharmacol 1999; 58(5): 811–816.

18.

Lari

Rashedinia

Abnous

. Alteration of protein profile in rat liver of animals exposed to subacute diazinon: a proteomic approach. Electrophoresis 2014; 35(10): 1419–1427.

19.

Lazareva-Ulitsky

Loo

. The PANTHER database of protein families, subfamilies, functions and pathways. Nucleic acids Res 2005; 33(suppl 1): D284–D288.

20.

De Silva

Samarawickrema

Wickremasinghe

. Toxicity due to organophosphorus compounds: what about chronic exposure? Trans R Soc Trop Med Hyg 2006; 100(9): 803–806.

21.

Vidyasagar

Karunakar

Reddy

. Oxidative stress and antioxidant status in acute organophosphorous insecticide poisoning. Indian J Pharmacol 2004; 36(2): 76.

22.

Spodniewska

Zasadowski

. Content of glutathione and vitamin C in the liver of rats exposed to dimethoate and pyrantel tartrate. Acta Vet Brno 2008; 77(3): 355–362.

23.

Sivapiriya

Venkatraman

. Effects of dimethoate (O, O-dimethyl S-methyl carbamoyl methyl phosphorodithioate) and ethanol in antioxidant status of liver and kidney of experimental mice. Pestic Biochem Physiol 2006; 85(2): 115–121.

24.

Hiyoshi

Konishi

Uemura

. d-Dopachrome tautomerase is a candidate for key proteins to protect the rat liver damaged by carbon tetrachloride. Toxicology 2009; 255(1): 6–14.

25.

Heiduschka

Blitgen-Heinecke

Tura

. Melanin precursor 5,6-dihydroxyindol: protective effects and cytotoxicity on retinal cells in vitro and in vivo. Toxicol Pathol 2007; 35(7): 1030–1038.

26.

Yang

Yan

. Expression of hepatitis B virus proteins in transgenic mice alters lipid metabolism and induces oxidative stress in the liver. J Hepatol 2008; 48(1): 12–19.

27.

Kolch

. Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem J 2000; 351: 289–305.

28.

Rosner

. MAP kinase meets mitosis: A role for Raf Kinase Inhibitory Protein in spindle checkpoint regulation. Cell Div 2007; 2(1): 1.

29.

Chatterjee

Bai

Wang

. RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis. J Biol Chem 2004; 279(17): 17515–17523.

30.

Keller

Yeung

. Raf kinase inhibitor protein: a prostate cancer metastasis suppressor gene. Canc Lett 2004; 207(2): 131–137.

31.

Kitagawa

Shen

. Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer. Prostate 2006; 66(3): 248–256.

32.

Odabaei

Chatterjee

Jazirehi

. Raf-1 kinase inhibitor protein: structure, function, regulation of cell signaling, and pivotal role in apoptosis. Adv Canc Res 2004; 91: 169–200.

33.

Feldmann

Jr Feldmann

Jr Maurer

. Reduction in rat phosphatidylethanolamine binding protein-1 (PEBP1) after chronic corticosterone treatment may be paralleled by cognitive impairment: a first study. Stress 2008; 11(2): 134–147.

34.

Smit

Pavel

. Induction of cytotoxicity in melanoma cells through inhibition of catechol-O-methyltransferase. Biochem Pharmacol 1995; 50(12): 1955–1962.

35.

Liehr

. Genotoxic effects of estrogens. Mut Res/Rev Gene Toxicol 1990; 238(3): 269–276.

36.

Liehr

Wan-Fen

Sirbasku

. Carcinogenicity of catechol estrogens in Syrian hamsters. J Steroid Biochem 1986; 24(1): 353–356.

37.

Liehr

Roy

. Free radical generation by redox cycling of estrogens. Free Rad Biol Med 1990; 8(4): 415–423.

38.

Liehr

Ulubelen

Strobel

. Cytochrome P-450-mediated redox cycling of estrogens. J Biol Chem 1986; 261(36): 16865–16870.

39.

Musrati

Kollarova

Mernik

. Malate dehydrogenase: distribution, function and properties. Gen Physiol Biophys 1998; 17: 193–210.

40.

Ozer

Ratner

Shaw

. The current state of serum biomarkers of hepatotoxicity. Toxicology 2008; 245(3): 194–205.

41.

Sastry

Malik

. Acute and chronic effects of diazinon on the activities of three dehydrogenases in the digestive system of a freshwater teleost fish Channa punctatus . Toxicol Lett 1982; 10(1): 55–59.

42.

Betarbet

Sherer

Greenamyre

. Ubiquitin–proteasome system and Parkinson’s diseases. Exp Neurol 2005; 191: S17–S27.

43.

Lodish

Berk

Zipursky

. Molecular cell biology. New York: W. H. Freeman; 2000.

44.

Lasram

Dhouib

Annabi

. A review on the molecular mechanisms involved in insulin resistance induced by organophosphorus pesticides. Toxicology 2014; 322: 1–13.

45.

Fujioka

Casida

. Glutathione S-transferase conjugation of organophosphorus pesticides yields S-phospho-, S-aryl-, and S-alkylglutathione derivatives. Chem Res Toxicol 2007; 20(8): 1211–1217.

46.

Zhang

Hou

Y-J

Han

S-Y

. Mammalian nitrilase 1 homologue Nit1 is a negative regulator in T cells. Int Immunol 2009; 21(6): 691–703.

47.

van Genderen

Kenis

Hofstra

. Extracellular annexin A5: functions of phosphatidylserine-binding and two-dimensional crystallization. Biochim Biophys Acta (BBA)-Mol Cell Res 2008; 1783(6): 953–963.

48.

Harashima

Harada

Ito

. Annexin A3 expression increases in hepatocytes and is regulated by hepatocyte growth factor in rat liver regeneration. J Biochem 2008; 143(4): 537–545.

49.

Xie

. Prognostic value of Annexin A3 in human colorectal cancer and its correlation with hypoxia-inducible factor-1α. Oncol Lett 2013; 6(6): 1631–1635.

50.

Yan

Yin

Yao

. Increased expression of annexin A3 is a mechanism of platinum resistance in ovarian cancer. Canc Res 2010; 70(4): 1616–1624.

51.

Park

Lee

. Annexin A3 is a potential angiogenic mediator. Biochem Biophys Res Commun 2005; 337(4): 1283–1287.

52.

Engel

Kiema

Hiltunen

. The crystal structure of enoyl-CoA hydratase complexed with octanoyl-CoA reveals the structural adaptations required for binding of a long chain fatty acid-CoA molecule. J Mol Biol 1998; 275(5): 847–859.

53.

Porter

Baskin

. Specificity studies of 3-mercaptopyruvate sulfurtransferase. J Biochem Toxicol 1995; 10(6): 287–292.

54.

Nagahara

Nagano

Ito

. Antioxidant enzyme, 3-mercaptopyruvate sulfurtransferase-knockout mice exhibit increased anxiety-like behaviors: a model for human mercaptolactate-cysteine disulfiduria. Sci Rep 2013; 3: 1986.

55.

Manevich

Fisher

. Peroxiredoxin 6, a 1-Cys peroxiredoxin, functions in antioxidant defense and lung phospholipid metabolism. Free Rad Biol Med 2005; 38(11): 1422–1432.

56.

Kim

Chun

Lee

. Phospholipase A2 of peroxiredoxin 6 has a critical role in tumor necrosis factor-induced apoptosis. Cell Death Differ 2011; 18(10): 1573–1583.